Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors-Reference-Cited by-同舟云学术

Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors

Published:2010-06-30 Issue:8 Volume:28 Page:849-855
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Simon Tchekmedyian N.,Chen Yin-Miao,Saad Fred

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2010.483508

Reference21 articles.

1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies

2. Clinical Benefits and Considerations of Bisphosphonate Treatment in Metastatic Bone Disease

4. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer

5. Pathologic fractures correlate with reduced survival in patients with malignant bone disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of bone complications in patients with genitourinary malignancies;Urologic Oncology: Seminars and Original Investigations;2020-03

2. Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry;BMJ Open;2020-02

3. Predictors of skeletal‐related events and mortality in men with metastatic, castration‐resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database;Cancer;2019-08-07

4. Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries;Journal of Bone Oncology;2016-11

5. Bone metastases in patients with small cell lung carcinoma: rate of development, early versus late onset, modality of treatment, and their impact on survival. A single-institution retrospective cohort study;Clinical & Experimental Metastasis;2016-05-21